The Neurotechnology Group at ETH Zurich is recruiting postdoctoral researchers and PhD students for a newly funded LOOP Zurich Flagship Project aimed at advancing a breakthrough technology for non-invasive targeted drug delivery to the brain. The laboratory has developed a focused ultrasound-mediated targeted drug delivery platform that enables localized, hyper-efficient delivery of therapeutic compounds to specific brain regions without invasive surgery. The project integrates carrier formulation chemistry, chemical engineering, medical imaging, real-time sensing, and intelligent control into a unified system, establishing a new paradigm for precision neurotherapeutics and opening opportunities for treating various neurological disorders.
Dieses Unternehmensprofil wurde automatisch erstellt. Wenn du für ETH Zürich arbeitest, kannst du das Profil jetzt beanspruchen und verifizieren – kostenlos und in wenigen Minuten.
The Neurotechnology Group collaborates closely with scientists and clinicians from ETH Zurich, University of Zurich, University Hospital Zurich, and Swiss Epilepsy Clinic Lengg. PhD candidates and postdoctoral researchers are affiliated with the Institute of Neuroinformatics and participate in interdisciplinary research teams.